Skip to main content

Read an important notice regarding the data security incident McKesson reported on August 28, 2026. Read more.

Outpatient Administration of Teclistamab or Talquetamab for Multiple Myeloma (OPTec/OPTal)

Disease Type: Myelomas

Outpatient Administration of Teclistamab or Talquetamab for Multiple Myeloma (OPTec/OPTal)

Locations

Roanoke